Guido Poggi

10 Maugeri Street
Pavia, 27100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.

Journal: European journal of gastroenterology & hepatology

Published: July 22, 2025

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.

Journal: JHEP reports : innovation in hepatology

Published: July 30, 2024

Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.

Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.

Journal: JHEP reports : innovation in hepatology

Published: July 11, 2022

Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.

Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.

Journal: Cancers

Published: February 15, 2021

Real-world experience with obeticholic acid in patients with primary biliary cholangitis.

Real-world experience with obeticholic acid in patients with primary biliary cholangitis.

Journal: JHEP reports : innovation in hepatology

Published: September 10, 2020

A huge pancreatic mass.

A huge pancreatic mass.

Journal: Annals of gastroenterology

Published: May 26, 2016

Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy

Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy

Journal: Recenti progressi in medicina

Published: May 22, 2015

Microwave ablation of hepatocellular carcinoma.

Microwave ablation of hepatocellular carcinoma.

Journal: World journal of hepatology

Published: April 30, 2015

Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.

Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 28, 2014

Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.

Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 02, 2013

Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results.

Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results.

Journal: Anticancer research

Published: March 14, 2013

Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.

Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: August 09, 2012

Showing 1-12 of 21

Last Updated: 09/26/2026